Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | NQO2 | P16083 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | PRKDC | P78527 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2,4,6-Trimethoxybenzaldehyde SCHEMBL34873 | 0.87 | ERN1 (0.74) | ERN1LMNAALDH1A1ABCG2CYP1A1 | |
| SCHEMBL6268566 | 0.87 | ERN1 (0.52) | ERN1LMNAALDH1A1NQO2CYP19A1 | |
| 2,4,6-Trimethoxybenzaldehyde SCHEMBL28687257 | 0.85 | ERN1 (0.71) | ERN1LMNAALDH1A1ABCG2CYP1A1 | |
| SCHEMBL14612135 | 0.84 | ERN1 (0.47) | ERN1LMNAALDH1A1CYP1A1CYP1B1 | |
| 2,4,6-Trimethoxybenzaldehyde SCHEMBL28687256 | 0.83 | ERN1 (0.75) | ERN1LMNAALDH1A1ABCG2CYP1A1 | |
| SCHEMBL4101740 | 0.83 | ERN1 (0.46) | ERN1LMNAALDH1A1NQO2CYP19A1 | |
| SCHEMBL1225577 | 0.82 | ERN1 (0.52) | ERN1LMNAALDH1A1PRKDCKDM4E | |
| SCHEMBL29818620 | 0.82 | ERN1 (0.52) | ERN1LMNAALDH1A1NQO2CYP19A1 | |
| SCHEMBL2028440 | 0.81 | TTR (0.51) | ERN1LMNAALDH1A1CYP1A2KDM4E | |
| SCHEMBL12311288 | 0.80 | ERN1 (0.65) | ERN1LMNAALDH1A1ABCG2CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230148641-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2023-05-18 | — | — | US | claimed |
| EP-4125427-A1 | FLAVOR COMPOSITION | Firmenich SA (CH) | 2023-02-08 | — | — | EP | claimed |
| CN-115279206-A | Flavor composition | 弗门尼舍有限公司 | 2022-11-01 | — | — | CN | claimed |
| WO-2021198199-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2021-10-07 | — | — | WO | claimed |
| US-20250002631-A1 | Radically Polymerizable Materials For The Production Of Dental Molding With Little Discoloration | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2025-01-02 | — | — | US | disclosed |
| EP-4484436-A1 | RADICAL POLYMERISABLE MATERIALS FOR PRODUCING DENTAL MOULDED BODIES WITH LOW DISCOLORATION | Ivoclar Vivadent AG (LI) | 2025-01-01 | — | — | EP | disclosed |
| US-20230148641-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2023-05-18 | — | — | US | disclosed |
| EP-4125427-A1 | FLAVOR COMPOSITION | Firmenich SA (CH) | 2023-02-08 | — | — | EP | disclosed |
| CN-115279206-A | Flavor composition | 弗门尼舍有限公司 | 2022-11-01 | — | — | CN | disclosed |
| WO-2021198199-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2021-10-07 | — | — | WO | disclosed |
| US-9896415-B2 | Chalcone derivatives having an anti-allergic activity | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2018-02-20 | — | — | US | disclosed |
| EP-3150589-A1 | IRE-1A INHIBITORS | MannKind Corporation (US) | 2017-04-05 | — | — | EP | disclosed |
| US-20120107365-A1 | FILMS AND PARTICLES | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-05-03 | — | — | US | disclosed |
| US-20110152305-A1 | FILMS AND PARTICLES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| WO-2011024774-A1 | SECOND-ORDER NON-LINEAR OPTICAL COMPOUND AND NON-LINEAR OPTICAL ELEMENT COMPRISING SAME | 独立行政法人情報通信研究機構 (JP) | 2011-03-03 | — | — | WO | disclosed |
| US-20090047221-A1 | COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA | NIPRI LIMITED (GB) | 2009-02-19 | — | — | US | disclosed |
| US-20090047221-A1 | COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA | NIPRI LIMITED (GB) | 2009-02-19 | — | — | US | disclosed |
| US-20090047221-A1 | COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA | NIPRI LIMITED (GB) | 2009-02-19 | — | — | US | disclosed |
| EP-1807410-A1 | COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA | NIPRI Limited (GB) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006046071-A1 | COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA | NIPRI LIMITED (GB) | 2006-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152305-A1 | FILMS AND PARTICLES | APOB, PGF, ACTB | ERN1 4047/4885LMNA 220/4885ALDH1A1 2505/4885 |
| US-20250002631-A1 | Radically Polymerizable Materials For The Production Of Dental Molding With Little Discoloration | ORMDL3, ME1, MTR | ERN1 2034/4885LMNA 1570/4885ALDH1A1 194/4885 |
| US-20090047221-A1 | COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA | MKI67, TP53, CCNA1 | ERN1 1843/4885LMNA 585/4885ALDH1A1 209/4885 |
| US-20120107365-A1 | FILMS AND PARTICLES | APOB, PGF, ACTB | ERN1 4047/4885LMNA 220/4885ALDH1A1 2505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.